S&P 500

5.277,51

0,80%

Registrieren Sie sich für Echtzeit-Benachrichtigungen, benutzerdefinierte Portfolios und Marktbewegungen.

Registrieren

NOVN Novan Inc

0,0941

0,00 (0,00%)

31 Mai 2024 - Geschlossen

Verzögert um 15 Minuten

Form EFFECT - Notice of Effectiveness

Novan (NASDAQ:NOVN)
Historical Stock Chart
Von Mai 2024 bis Jun 2024

Novan (NASDAQ:NOVN)
Historical Stock Chart
Von Jun 2023 bis Jun 2024

News Novan Inc

Form EFFECT - Notice of Effectiveness
Donnerstag 2 Mai 2024 (1 Monat vor) • Edgar (US Regulatory)

Form POS AM - Post-Effective amendments for registration statement
Mittwoch 1 Mai 2024 (1 Monat vor) • Edgar (US Regulatory)

Novartis expands production of Pluvicto™ with addition of its largest and most advanced radioligand therapy manufacturing facility in Indianapolis
Freitag 5 Januar 2024 (5 Monate vor) • GlobeNewswire Inc.

Novartis presents new 48-week results from Phase III APPLY-PNH trial showing sustained efficacy and long-term safety of Fabhalta® (iptacopan) in adults with paroxysmal nocturnal hemoglobinuria (PNH)
Montag 11 Dezember 2023 (6 Monate vor) • GlobeNewswire Inc.

Latest Novartis Kisqali® NATALEE analysis reinforces 25% reduction in risk of recurrence across broad population of patients with early breast cancer; supports regulatory submissions
Freitag 8 Dezember 2023 (6 Monate vor) • GlobeNewswire Inc.

Novartis receives FDA approval for Fabhalta® (iptacopan), offering superior hemoglobin improvement in the absence of transfusions as the first oral monotherapy for adults with PNH
Mittwoch 6 Dezember 2023 (6 Monate vor) • GlobeNewswire Inc.

Novartis showcases significant data updates from Kisqali®, iptacopan and Scemblix® at SABCS and ASH
Montag 20 November 2023 (6 Monate vor) • GlobeNewswire Inc.

Form 8-K - Current report
Dienstag 24 Oktober 2023 (7 Monate vor) • Edgar (US Regulatory)

Form 8-K - Current report
Freitag 20 Oktober 2023 (7 Monate vor) • Edgar (US Regulatory)

Form 8-K - Current report
Donnerstag 7 September 2023 (9 Monate vor) • Edgar (US Regulatory)

Form 8-K - Current report
Donnerstag 24 August 2023 (9 Monate vor) • Edgar (US Regulatory)

Form 8-K - Current report
Mittwoch 26 Juli 2023 (10 Monate vor) • Edgar (US Regulatory)

Weitere Novan Inc News-Artikel

Support: +44 (0) 203 8794 460 | support@advfn.de

Durch das Benutzen des ADVFN Angebotes akzeptieren Sie folgende Allgemeine Geschäftsbedingungen

Marktdaten

News

Werkzeuge

Märkte

Entdecken

Hot Features

Follow Feed

Optionen-Flow

Watchlist

NOVN Novan Inc

News Novan Inc

Kürzlich von Ihnen besucht

Unternehmen

Geschäft

Popular

App herunterladen

Trends

Toplisten

Marktdaten

News

Werkzeuge

Märkte

Entdecken

Hot Features

Follow Feed

Optionen-Flow

Watchlist

NOVN Novan Inc

News Novan Inc

Kürzlich von Ihnen besucht

Unternehmen

Geschäft

Popular

App herunterladen